Patent · US Active

Compositions and methods for treating or preventing lupus

US10017762B2 · kind B2 · utility

0Cited by

14References

10Claims

0Family size

Assignee

The United States of America, as represented by the Secretary, Department of Health and Human Services · US

Inventors

Juan Rivera · Patillas, US
Nicolas Charles · Asnières-sur-Seine, FR

Key dates

Filing date	Apr 26, 2017
Grant date	Jul 10, 2018
Priority date	—
Expiry date	Apr 26, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/505
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure provides methods for inhibiting and/or reducing self-reactive IgE and/or basophils, thereby treating or preventing lupus, lupus nephritis, and lupus-related disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.